Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amvuttra
Pharma
BridgeBio’s Attruby cruises toward blockbuster land
As Alnylam’s Amvuttra sales disappointed, revenue from BridgeBio’s rival ATTR drug Attruby came above analysts’ expectations.
Angus Liu
Aug 11, 2026 11:22am
Alnylam shares tank 29% as Amvuttra disappoints
Jul 30, 2026 11:35am
Alnylam scolded over promotional activity after Pfizer complaint
Jun 22, 2026 9:46am
Alnylam rebuked by FDA over efficacy claims on Amvuttra website
May 7, 2026 5:18am
As questions swirl, Alnylam eyes ATTR market leadership by 2030
Mar 26, 2026 2:08pm
Orphan drug sales to surge past $400B in 2032: report
Mar 12, 2026 8:20am
